METHODS AND USES OF BIOLOGICAL TISSUES FOR VARIOUS STENT AND OTHER MEDICAL APPLICATIONS
Methods and uses of biological tissues for various stent and other medical applications. In an exemplary embodiment of a method of processing a tissue of the present disclosure, the method comprises the steps of acquiring a mammalian tissue comprising at least a portion of a pulmonary region tissue, selecting a sample of pulmonary region tissue from the at least a portion of a pulmonary region tissue, and fixing the sample of pulmonary region tissue using a fixative, resulting in a fixed sample. In at least one embodiment, the step of selecting a sample of pulmonary region tissue comprises selecting a sample of pulmonary ligament tissue from the mammalian tissue.
1 . A product, comprising:
a frame configured to retain a mammalian tissue thereon; and
the mammalian tissue coupled to the frame;
wherein when the product is positioned within a mammalian luminal organ, fluid native to the mammalian luminal organ may pass through a lumen defined within the product;
wherein the product is configured as a stent valve;
wherein the mammalian tissue comprises visceral pleura; and
wherein the mammalian tissue is chemically fixed.
2 . The product of claim 1 , wherein a segment of the mammalian tissue is decellularized.
3 . The product of claim 1 , wherein the visceral pleura is harvested from a middle-anterior portion of a lung.
4 . The product of claim 1 , wherein the mammalian tissue is fixed using a fixative selected from the group consisting of glutaraldehyde, formaldehyde, and glycerol.
5 . The product of claim 1 , wherein the mammalian tissue is fixed using a fixative within a HEPES or phosphate buffer.
6 . The product of claim 1 , wherein the mammalian tissue is fixed using a fixative that is buffered.
7 . The product of claim 1 , wherein the mammalian tissue is sterilized.
8 . The product of claim 1 , wherein the stent valve is configured for use as a venous valve.
9 . The product of claim 1 , wherein the frame comprises a material selected from the group consisting of nitinol, chromium, cadmium, molybdenum, nickel, a nickel composite, nickel-cadmium nickel-chromium, nitinol palladium, palladium, cobalt, platinum, and stainless steel.
10 . A product, comprising:
a frame configured to retain a mammalian tissue thereon, the frame comprising a first end, a second end, a longitudinal axis, one or more lower arms, and at least one connection portion extending along the longitudinal axis, the one or more lower arms disposed at the second end and connected to the at least one connection portion, the at least one connection portion comprising connection bars; and
the mammalian tissue coupled to the frame;
wherein when the product is positioned within a mammalian luminal organ, fluid native to the mammalian luminal organ may pass through a lumen defined within the product;
wherein the product is configured as a stent valve;
wherein the mammalian tissue comprises visceral pleura;
wherein the at least one connection portion is used to connect the visceral pleura to the frame; and
wherein the mammalian tissue chemically is fixed.
11 . The product of claim 10 , wherein a segment of the mammalian tissue is decellularized.
12 . The product of claim 10 , wherein the visceral pleura is harvested from a middle-anterior portion of a lung.
13 . The product of claim 10 , wherein the mammalian tissue is fixed using a fixative selected from the group consisting of glutaraldehyde, formaldehyde, and glycerol.
14 . The product of claim 10 , wherein the mammalian tissue is sterilized.
15 . The product of claim 10 , wherein the stent valve is configured for use as a venous valve.
16 . The product of claim 10 , wherein the frame comprises a material selected from the group consisting of nitinol, chromium, cadmium, molybdenum, nickel, a nickel composite, nickel-cadmium nickel-chromium, nitinol palladium, palladium, cobalt, platinum, and stainless steel.
17 . A product, comprising:
a frame configured to retain a mammalian tissue thereon, the frame comprising a first end, a second end, a longitudinal axis, one or more lower arms, and at least one connection portion extending along the longitudinal axis, the one or more lower arms disposed at the second end and connected to the at least one connection portion, the at least one connection portion comprising connection bars; and
the mammalian tissue coupled to the frame;
wherein when the product is positioned within a mammalian luminal organ, fluid native to the mammalian luminal organ may pass through a lumen defined within the product;
wherein the product is configured as a bileaflet stent valve;
wherein the mammalian tissue comprises visceral pleura;
wherein the at least one connection portion is used to connect the visceral pleura to the frame; and
wherein the mammalian tissue is chemically fixed.
18 . A product of claim 1 , wherein the visceral pleura has a non-mesothelial side and a mesothelial side, the non-mesothelial side positioned such that it contacts fluid native to the mammalian luminal organ passing through the lumen defined within the product, the mesothelial side opposably facing the non-mesothelial side.
19 . A product of claim 1 , wherein the product has a first axial axis;
wherein the visceral pleura has a circumferential axis and a second axial axis, the visceral pleura being stiffer along the second axial axis relative to the circumferential axis; and
wherein the visceral pleura is coupled to the frame such that the circumferential axis is aligned with the first axial axis.
20 . The product of claim 1 , wherein the visceral pleura has a thickness between about 40 microns and about 300 microns.
21 . The product of claim 1 , wherein the visceral pleura has a thickness between about 40 microns and about 80 microns.
22 . The product of claim 1 , wherein the product is configured as a monocusp valve.
23 . The product of claim 1 , wherein the product is configured as a bileaflet valve.
24 . The product of claim 1 , wherein the product is configured as a tricuspid valve.